• Product nameAnti-PRRT2 antibody
    See all PRRT2 primary antibodies
  • Description
    Mouse polyclonal to PRRT2
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Full length human PRRT2 protein (AAH53594.1).

  • Positive control
    • PRRT2 transfected 293T lysate.


  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage bufferPreservative: None
    Constituents: 1X PBS, pH 7.2
  • Concentration information loading...
  • PurityProtein G purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas


Our Abpromise guarantee covers the use of ab70420 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Detects a band of approximately 30 kDa (predicted molecular weight: 35 kDa).


  • Involvement in diseaseEpisodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An autosomal dominant neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis. Note=The disease is caused by mutations affecting the gene represented in this entry. Disease-causing mutations that produce truncation of the C-terminus of the protein alter subcellular location, from plasma membrane to cytosplasm (PubMed:22101681).
    Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by clinical features of benign familial infantile seizures and episodic kinesigenic dyskinesia. Benign familial infantile seizures is a disorder characterized by afebrile seizures occurring during the first year of life, without neurologic sequelae. Paroxysmal choreoathetosis is a disorder of involuntary movements characterized by attacks that occur spontaneously or are induced by a variety of stimuli. Note=The disease is caused by mutations affecting the gene represented in this entry.
    Seizures, benign familial infantile 2 (BFIS2) [MIM:605751]: An autosomal dominant disorder in which afebrile seizures occur in clusters during the first year of life, without neurologic sequelae. Note=The disease is caused by mutations affecting the gene represented in this entry.
  • Sequence similaritiesBelongs to the CD225/Dispanin family.
  • Cellular localizationCell membrane. Cell junction > synapse.
  • Information by UniProt
  • Database links
  • Alternative names
    • interferon induced transmembrane protein domain containing 1 antibody
    • BFIC2 antibody
    • BFIS2 antibody
    • Dispanin subfamily B member 3 antibody
    • DSPB3 antibody
    • Dystonia 10 antibody
    • DYT10 antibody
    • EKD1 antibody
    • FICCA antibody
    • FLJ25513 antibody
    • ICCA antibody
    • IFITMD1 antibody
    • Infantile convulsions and paroxysmal choreoathetosis antibody
    • PKC antibody
    • Proline rich transmembrane protein 2 antibody
    • Proline-rich transmembrane protein 2 antibody
    • PRRT2 antibody
    • PRRT2_HUMAN antibody
    see all

Anti-PRRT2 antibody images

  • All lanes : Anti-PRRT2 antibody (ab70420) at 1/500 dilution

    Lane 1 : PRRT2 transfected 293T lysate
    Lane 2 : Non-transfected 293T lysate

    Lysates/proteins at 25 µg per lane.

    Goat Anti-Mouse IgG (H&L)-HRP at 1/2500 dilution

    Predicted band size : 35 kDa
    Observed band size : 30 kDa (why is the actual band size different from the predicted?)

References for Anti-PRRT2 antibody (ab70420)

ab70420 has not yet been referenced specifically in any publications.

Product Wall

Vielen Dank Ihre Anfrage.

Da es sich bei diesem Antikörper um einen polyklonalen Antikörper handelt, der gegen gesamte Protein gerichtet ist, gibt es kein spezifisches Epitop: Dieser Antikörper ist ein Gemisch aus Antikör...

Read More